PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, ...
Stocktwits on MSN
Amaze Extends Partnership with Adobe Express, Expands Platform Access to Creators in India
Next phase of collaboration broadens access to integration e-commerce and design tools for global creatorsNEWPORT BEACH, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: ...
TipRanks on MSN
PetMed Express Delays Quarterly Report Filing
Petmed Express ( ($PETS) ) has released a notification of late filing. PetMed Express, Inc. has announced a delay in filing its Form 10-Q (Quarter ...
Explore the Q3 performance of The Gabelli Equity Trust (GAB), featuring top contributors Rolls Royce and AI-driven gains in ...
Buffett and Berkshire have held a few stocks in the portfolio for decades. Warren Buffett, the outgoing CEO of Berkshire Hathaway, is arguably the greatest investor of all time, so it's no surprise ...
Downtown Loveland’s Night on the Town event will take place at 5-9 p.m. Friday, Nov. 14. Downtown art galleries will hold openings and events, and businesses offer events and specials as well. Vintage ...
American Express continues to expand its customer base while maintaining a focus on premium products and younger demographics. The company acquired 3.2 million new proprietary cards in Q3 2025, with ...
Veradace Partners L.P., a significant shareholder of Tiptree Inc., with beneficial ownership of 5.0% of the outstanding common stock, today issued an open letter to fellow Tiptree shareholders ...
Veradace also published the following list of the top questions that it believes shareholders should direct to the Tiptree Board of Directors (the "Board") in light of the numerous value-destructive ...
One-time treatment of nex-z led to consistently rapid, deep and durable reduction in serum TTR through three years of ...
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results